Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-05
1996-05-28
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 546193, 546201, A61K 31445, C07D40104
Patent
active
055211968
ABSTRACT:
This invention provides novel 5-HT.sub.1F agonists which are useful for the treatment of migraine and associated disorders.
REFERENCES:
patent: 3850938 (1974-11-01), Derible et al.
patent: 4359468 (1982-11-01), Freter et al.
patent: 4530932 (1985-07-01), Clemence et al.
patent: 4710500 (1987-12-01), Perregaard
patent: 4742057 (1988-05-01), Ueda et al.
patent: 4997841 (1991-03-01), Oxford et al.
patent: 5001135 (1991-03-01), Oxford et al.
patent: 5017703 (1991-05-01), Matsuo et al.
patent: 5036078 (1991-07-01), Coates
patent: 5045550 (1991-09-01), Jaen
patent: 5066660 (1991-11-01), Oxford et al.
patent: 5118691 (1992-06-01), Jaen et al.
patent: 5187280 (1993-02-01), Jaen et al.
patent: 5216001 (1993-06-01), Perregaard
patent: 5298520 (1994-03-01), Baker et al.
patent: 5317025 (1994-05-01), BruzMagniez
patent: 5322851 (1994-06-01), Perregaard
Tacconi et al. "Indole derivatives" CA 63:13193e (1965).
Wyngaarden et al. "Cecil Textbook of Medicine" Sauders Co., (1983) pp. 1940-1942.
Audia James E.
Nissen Jeffrey S.
Chang Ceila
Eli Lilly and Company
Jones Joseph A.
Titus Robert D.
LandOfFree
5-HT.sub.1F agonists for the treatment of migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-HT.sub.1F agonists for the treatment of migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-HT.sub.1F agonists for the treatment of migraine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-787161